Literature DB >> 8045437

Spontaneous evolution and photocoagulation of diabetic cystoid macular edema.

P Massin-Korobelnik1, A Gaudric, G Coscas.   

Abstract

Cystoid macular edema (CME) causes progressive visual impairment in diabetic patients and its treatment by photocoagulation remains unsatisfactory. We observed its spontaneous evolution for 3 years in 31 eyes. CME resolved in 9 eyes, was fluctuant in 16 and worsened in 7. Mean group visual acuity (VA) remained unchanged. Two modalities of photocoagulation were studied. In 27 eyes exhibiting CME combined with circinate exudates (group 1), extramacular focal photocoagulation was applied to the center of the exudates. Exudates disappeared from 23 eyes and CME from 12 eyes. Mean group VA remained unchanged. In 24 eyes with CME but without exudates (group 2), perifoveolar grid photocoagulation was applied over the CME area. CME disappeared from 15 eyes. Mean VA remained unchanged. These results show that CME with exudates requires a two-step treatment, comprising first focal photocoagulation, which clears exudates and often improves CME, and second--but only if CME persists and VA is below 0.5- perifoveolar grid photocoagulation, which often clears CME and stabilizes VA.

Entities:  

Mesh:

Year:  1994        PMID: 8045437     DOI: 10.1007/bf00194477

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  40 in total

1.  Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1990-09       Impact factor: 12.079

2.  The diabetic maculopathies.

Authors:  R A Whitelocke; M Kearns; R K Blach; A M Hamilton
Journal:  Trans Ophthalmol Soc U K       Date:  1979-07

3.  [Diabetic maculopathy. Spontaneous course].

Authors:  G Chaine; A Gaudric; E Ramioul; G Coscas
Journal:  Bull Soc Ophtalmol Fr       Date:  1986 Aug-Sep

4.  [Management of cystoid macular edema using perifoveolar photocoagulation with argon lasers].

Authors:  J Haut; G Van Effenterre; M Flamand; J Dureuil; M Cahiza
Journal:  Bull Soc Ophtalmol Fr       Date:  1980-01

5.  Focal photocoagulation of diabetic macular edema. A clinicopathologic case report.

Authors:  I H Wallow; C D Bindley
Journal:  Retina       Date:  1988       Impact factor: 4.256

6.  Treatment of diffuse diabetic macular oedema: a comparison between argon and krypton lasers.

Authors:  A G Casswell; C R Canning; Z J Gregor
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

7.  Diabetic maculopathy. A critical review highlighting diffuse macular edema.

Authors:  G H Bresnick
Journal:  Ophthalmology       Date:  1983-11       Impact factor: 12.079

8.  [Treatment of diabetic cystoid macular edema by argon laser photocoagulation].

Authors:  A Gaudric; E Ramioul; G Chaine; G Coscas
Journal:  J Fr Ophtalmol       Date:  1984       Impact factor: 0.818

9.  Grid photocoagulation improves reading ability in diffuse diabetic macular oedema.

Authors:  E I McNaught; W S Foulds; D Allan
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

10.  Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.

Authors:  C M Lee; R J Olk
Journal:  Ophthalmology       Date:  1991-10       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.